Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017 (2017), Article ID 3256241, 13 pages
https://doi.org/10.1155/2017/3256241
Research Article

Dietary Flaxseed Oil Prevents Western-Type Diet-Induced Nonalcoholic Fatty Liver Disease in Apolipoprotein-E Knockout Mice

Department of Nutrition and Food Hygiene, School of Public Health, Shanxi Medical University, No. 56, Xinjian South Road, Taiyuan, Shanxi 030001, China

Correspondence should be addressed to Hao Han; moc.621@99774131xxhh

Received 15 April 2017; Revised 28 June 2017; Accepted 5 July 2017; Published 7 September 2017

Academic Editor: Massimo Collino

Copyright © 2017 Hao Han et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Ahmed, “Non-alcoholic fatty liver disease in 2015,” World Journal of Hepatology, vol. 7, no. 11, pp. 1450–1459, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Lazo, R. Hernaez, M. S. Eberhardt et al., “Prevalence of nonalcoholic fatty liver disease in the United States: the third national health and nutrition examination survey, 1988-1994,” American Journal of Epidemiology, vol. 178, no. 1, pp. 38–45, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. V. W. Wong, “Nonalcoholic fatty liver disease in Asia: a story of growth,” Journal of Gastroenterology and Hepatology, vol. 28, no. 1, pp. 18–23, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Amirkalali, H. Poustchi, H. Keyvani et al., “Prevalence of non-alcoholic fatty liver disease and its predictors in north of Iran,” Iranian Journal of Public Health, vol. 43, no. 9, pp. 1275–1283, 2014. View at Google Scholar
  5. A. K. Panda, R. Avasthi, and G. Nath, “The association of cardiovascular risk factors and prevalence of MetS in non-alcoholic fatty liver disease (NAFLD),” Journal of the Association of Physicians of India, vol. 64, no. 1, p. 48, 2016. View at Google Scholar
  6. J. C. Cohen, J. D. Horton, and H. H. Hobbs, “Human fatty liver disease: old questions and new insights,” Science, vol. 332, no. 6037, pp. 1519–1523, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Eshraghian, “High prevalence of nonalcoholic fatty liver disease in the middle east: lifestyle and dietary habits,” Hepatology, vol. 65, no. 3, p. 1077, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Rusu, G. Enache, M. Jinga et al., “Medical nutrition therapy in non-alcoholic fatty liver disease--a review of literature,” Journal of Medicine and Life, vol. 8, no. 3, pp. 258–262, 2015. View at Google Scholar
  9. K. Nakamoto, T. Obata, A. Hirasawa, K. I. Kim, S. R. Kim, and S. Tokuyama, “A future perspective on the involvement of n-3 polyunsaturated fatty acid in the development of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis,” Yakugaku Zasshi, vol. 136, no. 4, pp. 583–589, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Delarue and J. P. Lallès, “Nonalcoholic fatty liver disease: roles of the gut and the liver and metabolic modulation by some dietary factors and especially long-chain n-3 PUFA,” Molecular Nutrition & Food Research, vol. 60, no. 1, pp. 147–159, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. W. Lu, S. Li, J. Li et al., “Effects of omega-3 fatty acid in nonalcoholic fatty liver disease: a meta-analysis,” Gasteroenterology Research and Practice, vol. 2016, Article ID 1459790, 11 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Yuan, H. Wang, Y. Tian et al., “Fish oil alleviated high-fat diet-induced non-alcoholic fatty liver disease via regulating hepatic lipids metabolism and metaflammation: a transcriptomic study,” Lipids in Health and Disease, vol. 15, p. 20, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Xu, H. Gao, L. Song et al., “Flaxseed oil and alpha-lipoic acid combination ameliorates hepatic oxidative stress and lipid accumulation in comparison to lard,” Lipids in Health and Disease, vol. 12, no. 1, p. 58, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. X. Zhang, H. Wang, P. Yin, H. Fan, L. Sun, and Y. Liu, “Flaxseed oil ameliorates alcoholic liver disease via anti-inflammation and modulating gut microbiota in mice,” Lipids in Health and Disease, vol. 16, no. 1, p. 44, 2017. View at Publisher · View at Google Scholar
  15. J. Xu, S. Rong, H. Gao et al., “A combination of flaxseed oil and astaxanthin improves hepatic lipid accumulation and reduces oxidative stress in high fat-diet fed rats,” Nutrients, vol. 9, no. 3, p. 271, 2017. View at Publisher · View at Google Scholar
  16. Y. Nakashima, A. S. Plump, E. W. Raines, J. L. Breslow, and R. Ross, “ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree,” Arteriosclerosis Thrombosis and Vascular Biology, vol. 14, no. 1, pp. 133–140, 1994. View at Publisher · View at Google Scholar
  17. H. Han, W. Cui, L. Wang et al., “Lutein prevents high fat diet-induced atherosclerosis in ApoE-deficient mice by inhibiting NADPH oxidase and increasing PPAR expression,” Lipids, vol. 50, no. 3, pp. 261–273, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Ohkawa, N. Ohishi, and K. Yagi, “Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction,” Analytical Biochemistry, vol. 95, no. 2, pp. 351–358, 1979. View at Publisher · View at Google Scholar · View at Scopus
  19. J. J. Eady, T. Orta, M. F. Dennis, M. R. Stratford, and J. H. Peacock, “Glutathione determination by the Tietze enzymatic recycling assay and its relationship to cellular radiation response,” British Journal of Cancer, vol. 72, no. 5, pp. 1089–1095, 1995. View at Google Scholar
  20. Y. Kono, “Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase,” Archives of Biochemistry and Biophysics, vol. 186, no. 5, pp. 189–195, 1978. View at Publisher · View at Google Scholar · View at Scopus
  21. E. F. Hartree, “Determination of protein: a modification of the Lowry method that gives a linear photometric response,” Analytical Biochemistry, vol. 48, no. 2, pp. 422–427, 1972. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Motamed, B. Rabiee, H. Poustchi et al., “Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases,” Clinical Gastroenterology and Hepatology, vol. 41, no. 1, pp. 31–38, 2016. View at Publisher · View at Google Scholar
  23. F. Bril and K. Cusi, “Nonalcoholic fatty liver disease: the new complication of type 2 diabetes mellitus,” Endocrinology and Metabolism Clinics of North America, vol. 45, no. 4, pp. 765–781, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. R. M. Carr, A. Oranu, and V. Khungar, “Nonalcoholic fatty liver disease: pathophysiology and management,” Gastroenterology Clinics of North America, vol. 45, no. 4, pp. 639–652, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Musso, R. Gambino, and M. Cassader, “Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD),” Progress in Lipid Research, vol. 48, no. 1, pp. 1–26, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Wang, X. J. Zhang, K. Feng et al., “Dietary α-linolenic acid-rich flaxseed oil prevents against alcoholic hepatic steatosis via ameliorating lipid homeostasis at adipose tissue-liver axis in mice,” Scientific Reports, vol. 6, article 26826, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Han, P. Yan, L. Chen et al., “Flaxseed oil containing α-linolenic acid ester of plant sterol improved atherosclerosis in apoE deficient mice,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 958217, 17 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. A. De Tonnac, E. Labussière, A. Vincent, and J. Mourot, “Effect of α-linolenic acid and DHA intake on lipogenesis and gene expression involved in fatty acid metabolism in growing-finishing pigs,” British Journal of Nutrition, vol. 116, no. 1, pp. 7–18, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Kawano and D. E. Cohen, “Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease,” Journal of Gastroenterology, vol. 48, no. 4, pp. 434–441, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Qin, J. Yin, and K. Huang, “Free fatty acids increase intracellular lipid accumulation and oxidative stress by modulating PPARα and SREBP-1c in L-02 cells,” Lipids, vol. 51, no. 7, pp. 797–805, 2016. View at Publisher · View at Google Scholar · View at Scopus
  31. P. P. Devarshi, N. M. Jangale, A. E. Ghule, S. L. Bodhankar, and A. M. Harsulkar, “Beneficial effects of flaxseed oil and fish oil diet are through modulation of different hepatic genes involved in lipid metabolism in streptozotocin-nicotinamide induced diabetic rats,” Genes & Nutrition, vol. 8, no. 3, pp. 329–342, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Su, C. Ma, C. Liu, C. Gao, R. Nie, and H. Wang, “Hypolipidemic activity of peony seed oil rich in α-linolenic, is mediated through inhibition of lipogenesis and upregulation of fatty acid β-oxidation,” Journal of Food Science, vol. 81, no. 4, pp. 1001–1009, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Tanaka, X. Zhang, E. Sugiyama et al., “Eicosapentaenoic acid improves hepatic steatosis independent of PPARα activation through inhibition of SREBP-1 maturation in mice,” Biochemical Pharmacology, vol. 80, no. 10, pp. 1601–1612, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. G. A. Preidis, K. H. Kim, and D. D. Moore, “Nutrient-sensing nuclear receptors PPARα and FXR control liver energy balance,” Journal of Clinical Investigation, vol. 127, no. 4, pp. 1193–1201, 2017. View at Publisher · View at Google Scholar
  35. M. Á. Rincón-Cervera, R. Valenzuela, M. C. Hernandez-Rodas et al., “Vegetable oils rich in alpha linolenic acid increment hepatic n-3 LCPUFA, modulating the fatty acid metabolism and antioxidant response in rats,” Prostaglandins, Leukotrienes, and Essential Fatty Acids, vol. 111, pp. 25–35, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Petta, A. Gastaldelli, E. Rebelos et al., “Pathophysiology of non alcoholic fatty liver disease,” International Journal of Molecular Sciences, vol. 17, no. 12, article E2082, 2016. View at Publisher · View at Google Scholar · View at Scopus
  37. V. Maillet, V. Paradis, D. Couton et al., “Oxidative stress promotes pathologic polyploidization in nonalcoholic fatty liver disease,” Journal of Clinical Investigation, vol. 125, no. 3, pp. 981–992, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. N. M. Jangale, P. P. Devarshi, S. B. Bansode, M. J. Kulkarni, and A. M. Harsulkar, “Dietary flaxseed oil and fish oil ameliorates renal oxidative stress, protein glycation, and inflammation in streptozotocin-nicotinamide-induced diabetic rats,” Journal of Physiology and Biochemistry, vol. 72, no. 2, pp. 327–336, 2016. View at Publisher · View at Google Scholar · View at Scopus
  39. A. F. Ismail, A. A. Salem, and M. M. Eassawy, “Modulation of gamma-irradiation and carbon tetrachloride induced oxidative stress in the brain of female rats by flaxseed oil,” Journal of Photochemistry and Photobiology B, vol. 161, pp. 91–99, 2016. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Sakamoto, H. Tsujikawa, K. Effendi et al., “Pathological findings of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease,” Pathology International, vol. 67, no. 1, pp. 1–7, 2017. View at Publisher · View at Google Scholar
  41. M.Y. Kim, “The Progression of Liver Fibrosis in Non-alcoholic Fatty Liver Disease,” The Korean Journal of Gastroenterology, vol. 69, no. 6, pp. 341–347, 2017. View at Publisher · View at Google Scholar
  42. V. Ajmera, E. R. Perito, N. M. Bass et al., “Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease,” Hepatology, vol. 65, no. 1, pp. 65–77, 2017. View at Publisher · View at Google Scholar
  43. S. A. Polyzos, J. Kountouras, V. Polymerou, K. G. Papadimitriou, C. Zavos, and P. Katsinelos, “Vaspin, resistin, retinol-binding protein-4, interleukin-1α and interleukin-6 in patients with nonalcoholic fatty liver disease,” Annals of Hepatology, vol. 15, no. 5, pp. 705–714, 2016. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Y. Hendawi, R. T. Alam, and S. A. Abdellatief, “Ameliorative effect of flaxseed oil against thiacloprid-induced toxicity in rats: hematological, biochemical, and histopathological study,” Environmental Science and Pollution Research International, vol. 23, no. 12, pp. 11855–11863, 2016. View at Publisher · View at Google Scholar · View at Scopus
  45. S. C. Sun, “The non-canonical NF-κB pathway in immunity and inflammation,” Nature Reviews Immunology, 2017. View at Publisher · View at Google Scholar
  46. D. Y. Tan, H. Y. Shi, C. P. Li, X. L. Zhong, and M. Kang, “Effect of nuclear factor-κB and angiotensin II receptor type 1 on the pathogenesis of rat non-alcoholic fatty liver disease,” World Journal of Gastroenterology, vol. 21, no. 19, pp. 5877–5883, 2015. View at Publisher · View at Google Scholar · View at Scopus
  47. L. Li, J. Hai, Z. Li et al., “Resveratrol modulates autophagy and NF-κB activity in a murine model for treating non-alcoholic fatty liver disease,” Food and Chemical Toxicology, vol. 63, pp. 166–173, 2014. View at Publisher · View at Google Scholar · View at Scopus
  48. L. Wu and Y. Xie, “Effect of NF-κB on the pathogenic course of non-alcoholic fatty liver disease,” Zhong Nan Da Xue Xue Bao. Yi Xue Ban, vol. 42, no. 4, pp. 463–467, 2017. View at Publisher · View at Google Scholar
  49. L. A. Videla, G. Tapia, R. Rodrigo et al., “Liver NF-κB and AP-1 DNA binding in obese patients,” Obesity, vol. 17, no. 5, pp. 973–979, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Dela Pena, I. Leclercq, J. Field, J. George, B. Jones, and G. Farrell, “NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis,” Gastroenterology, vol. 129, no. 5, pp. 1663–1674, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. J. M. Monk, D. M. Liddle, M. J. Brown et al., “Anti-inflammatory and anti-chemotactic effects of dietary flaxseed oil on CD8+ T cell/adipocyte-mediated cross-talk,” Molecular Nutrition & Food Research, vol. 60, no. 3, pp. 621–630, 2016. View at Publisher · View at Google Scholar · View at Scopus
  52. H. J. Park, J. Y. Lee, M. Y. Chung et al., “Green tea extract suppresses NFκB activation and inflammatory responses in diet-induced obese rats with nonalcoholic steatohepatitis,” Journal of Nutrition, vol. 142, no. 1, pp. 57–63, 2012. View at Publisher · View at Google Scholar · View at Scopus